XBOW uses AI reasoning and adversarial workflows to continuously test applications for security flaws. Unlike traditional point-in-time penetration testing, the platform operates autonomously to identify and validate vulnerabilities at machine speed, aiming to keep pace with both modern development cycles and AI-powered attackers.
Integrating security and asset data from over 200 connectors, the platform unifies business context and AI-based intelligence into a single pane, offering visibility and enabling risk prioritization and reduction. Nucleus relies on automation to enhance customers' vulnerability management programs. It correlates flaws with real-world threat data from multiple sources, normalizes it, maps assets to specific teams, and uses workflows for faster remediation. According to Nucleus, its vendor-agnostic approach covers exposure across tools, users, environments, and business units, unifies context, and enables coordinated action.
I do think there's just fervor around 'Oh, you can sprinkle AI on top of any robot and magic will ensue,' Walti said. 'Then the value will compound at the rate we've seen with some of these other AI companies in say, voice or text. And I don't think that's the case. At a high level, where some of the hype and capital is going in robotics is perhaps a little misguided...'
We see a future where operating systems are significantly different from the ones today. Each system will know its user deeply, and be hyper-personalised to each individual. Interfaces will adapt to our context and needs. Suggestions will surface naturally, and once we confirm an intent, agents will execute on our behalf. The system will handle the non-essential for us, allowing us to focus on what truly matters, which will be different for every person. Unlike today's one-size-fits-all solution, a billion different operating systems will be rendered for a billion different people.
Glycomine's progress towards delivering the first disease-modifying therapy for a rare genetic disorder was bolstered by a $115 million Series C funding round.